ADx Healthcare is selling an APOE test on the Helix marketplace, while HealthLytix and Dash Genomics are marketing a polygenic hazard score for late-onset Alzheimer's.
A number of consumer genetic testing companies are adopting best practice guidelines for customer privacy, the Washington Post reports.
The company plans to use the new funding to grow its suite of genomics applications to more than 50 in 2018.
The firm acquired startup HumanCode, which had developed genetic testing apps around ancestry and wellness for the Helix platform.
At a time of rapid growth in the consumer genetics space, PerkinElmer and NorthShore are developing digital apps to ease access to genetic disease risk information through Helix.
PerkinElmer is working on an app that reports pathogenic or likely pathogenic ACMG-59 genetic variants, and NorthShore's app will report a prostate cancer risk score.
Researchers will study the genetic underpinnings of cancer, heart disease, and respiratory illness by delving into the exome sequencing data from 40,000 Northern Nevadans.
Helix expects its online store will grow this year to include more than 50 genomics apps, including new health products from partners like Geisinger and Mayo.
The company plans to use the additional funds to introduce new genomics app products within its online store this year.
An NPR reporter finds that ancestry results from genetic testing don't always reflect family history.
Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.
The Wall Street Journal looks into the cost of new gene therapies.
An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.
In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.